US Grants.gov · Open

Immune Tolerance Network (UM1 Clinical Trial Required)

Official call page ↗

The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.

Change history

First seen 28 Sept 2026, last checked 22 Nov 2026. 20 recorded versions.

  • 27 Oct 2026 · c924f269aabb
  • 22 Oct 2026 · e6c9bab340c3
  • 22 Oct 2026 · 0d1416130d5e
  • 21 Oct 2026 · 992a81dfa726
  • 20 Oct 2026 · 1febb05eb9b7
  • 19 Oct 2026 · b9589110b1da
  • 18 Oct 2026 · d616a6bf51d3
  • 17 Oct 2026 · d84c9dd30494
  • 16 Oct 2026 · f21d1c1b087c
  • 15 Oct 2026 · a9a51497c88e
  • 14 Oct 2026 · eee9a2a77fdd
  • 13 Oct 2026 · d8a61b840eb8
  • 12 Oct 2026 · 7ef87526472a
  • 11 Oct 2026 · 7dc0e655401e
  • 10 Oct 2026 · 34c9e7f32ea3
  • 09 Oct 2026 · 68353fa99b5b
  • 08 Oct 2026 · 19ae4a9fa7b6
  • 07 Oct 2026 · 40fd87661ab0
  • 05 Oct 2026 · 68353fa99b5b
  • 04 Oct 2026 · 6ca2578e7855

Report a problem with this record · How data is produced